ARCHIVES

Moses, Wattenberg Lead AACR; NCI Budget Cut By $4.8 Mil. For Shannon Awards Contribution

This article is from The Cancer Letter archive.

Vol. 17 No. 21 | May 24, 1991

Download PDF Visit The Full Archive

Related Articles

Cooperative Group chairmen Cool, But High Priority Trials To Continue

January 18, 1991

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

NCCS Networker Volume 5 Issue 2, Spring 1991

April 13, 1991

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009

NCAB Approves, NCI Accepts Powers’ Version Of Board’s Organ Systems Recommendations

May 27, 1983

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

November 7, 2008